AVEO Oncology
AVEO
#7396
Rank
NZ$0.95 B
Marketcap
NZ$27.34
Share price
0.00%
Change (1 day)
177.03%
Change (1 year)

EPS for AVEO Oncology (AVEO)

EPS in 2022 (TTM): NZ-$1.28

According to AVEO Oncology 's latest financial reports the company's current EPS (TTM) is NZ-$1.53. In 2021 the company made an earnings per share (EPS) of NZ-$3.13 a decrease over its 2020 EPS that were of NZ-$3.12.

EPS history for AVEO Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$1.28-59.03%
2021NZ-$3.130.58%
2020NZ-$3.12-375.81%
2019NZ$1.13-224%
2018NZ-$0.91-91.8%
2017NZ-$11.1252.5%
2016NZ-$7.29
2014NZ-$18.59
2012NZ-$47.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
NZ$56.30-3,777.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.67-2,169.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.30-380.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$85.62-5,692.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.24-638.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$25.26-1,750.00%๐Ÿ‡บ๐Ÿ‡ธ USA